Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,969,069
  • Shares Outstanding, K 36,482
  • Annual Sales, $ 560,410 K
  • Annual Income, $ -15,700 K
  • 60-Month Beta 0.29
  • Price/Sales 17.93
  • Price/Cash Flow 515.95
  • Price/Book 15.56
Trade PEN with:

Options Overview

Details
  • Implied Volatility 39.15%
  • Historical Volatility 32.26%
  • IV Percentile 8%
  • IV Rank 10.11%
  • IV High 93.47% on 01/29/21
  • IV Low 33.04% on 08/21/20
  • Put/Call Vol Ratio 1.50
  • Today's Volume 50
  • Volume Avg (30-Day) 186
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 7,805
  • Open Int (30-Day) 6,928

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.19
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.18
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +163.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
235.20 +16.18%
on 05/18/21
291.10 -6.13%
on 06/14/21
+38.26 (+16.28%)
since 05/17/21
3-Month
232.29 +17.63%
on 05/17/21
320.00 -14.61%
on 05/05/21
-13.48 (-4.70%)
since 03/17/21
52-Week
163.49 +67.14%
on 12/16/20
320.00 -14.61%
on 05/05/21
+101.86 (+59.43%)
since 06/17/20

Most Recent Stories

More News
AtriCure Names Two New Members to the Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been...

ATRC : 77.38 (+1.98%)
OGN : 31.46 (+2.48%)
MRK : 77.23 (+0.81%)
SRNE : 8.67 (-0.34%)
JCI : 65.93 (-1.98%)
ABT : 111.63 (+1.43%)
BA : 239.22 (-1.26%)
PEN : 273.26 (-0.77%)
TMO : 486.08 (+3.77%)
BSX : 43.35 (+1.33%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 127.00 (+1.16%)
GNMK : 24.04 (unch)
PEN : 273.26 (-0.77%)
IHI : 352.98 (+1.69%)
NARI : 90.01 (+0.33%)
Proactive news headlines including Peninsula Energy, Andromeda Metals, Ora Banda Mining and Buru Energy

Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

LIACF : 1.2700 (+1.08%)
PLL : 68.83 (-2.19%)
PDDTF : 0.6000 (+1.68%)
SYA : 32.02 (+0.09%)
DMNXF : 0.0485 (-3.00%)
KNEOF : 0.0079 (-12.22%)
PEN : 273.26 (-0.77%)
PENMF : 0.1250 (-3.85%)
ADN : 9.34 (-5.66%)
BRNGF : 0.1278 (+10.08%)
BUD : 77.03 (-2.00%)
ORG : 19.06 (-3.13%)
OGFGY : 3.6600 (+1.67%)
Penumbra, Inc. to Present at the William Blair 41st Annual Growth Stock Virtual Conference

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 41st Annual Growth Stock Virtual Conference on .

PEN : 273.26 (-0.77%)
Insights on the Neurovascular Devices Global Market to 2029 - Increasing Ageing Population in the Developed Nations Will Drive Growth

, /PRNewswire/ -- The report has been added to offering.

ABT : 111.63 (+1.43%)
MDT : 125.21 (+0.15%)
MMSI : 61.77 (+0.11%)
MCRPF : 8.7200 (+2.35%)
PEN : 273.26 (-0.77%)
SYK : 259.55 (+1.23%)
TRUMF : 41.9500 (-0.04%)
Penumbra (PEN) Q1 Earnings and Revenues Surpass Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 145.45% and 10.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

PEN : 273.26 (-0.77%)
Penumbra: Q1 Earnings Snapshot

ALAMEDA, Calif. (AP) _ Penumbra Inc. (PEN) on Tuesday reported first-quarter earnings of $11.8 million.

PEN : 273.26 (-0.77%)
Penumbra, Inc. Reports First Quarter 2021 Financial Results

, May 4, 2021 /PRNewswire/ -- Penumbra, Inc.(NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended .

PEN : 273.26 (-0.77%)
Penumbra, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Penumbra, Inc. (NYSE:PEN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 4, 2021 at 4:30 PM Eastern Time....

PEN : 273.26 (-0.77%)
Penumbra, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference on .

PEN : 273.26 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 283.59
2nd Resistance Point 280.93
1st Resistance Point 277.10
Last Price 273.26
1st Support Level 270.60
2nd Support Level 267.94
3rd Support Level 264.11

See More

52-Week High 320.00
Last Price 273.26
Fibonacci 61.8% 260.21
Fibonacci 50% 241.74
Fibonacci 38.2% 223.28
52-Week Low 163.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar